Andrea Schmetz, MBA, is Senior Consultant, Value and Access Consulting; Stephanie Wise, MPharm, is Consultant, Value and Access Consulting; Matthew Bending, PhD, is Executive Director of HTA Strategy and UK Practice Lead, Value and Access Consulting; and Patricia Hurley, PhD, is Senior Director, Strategic Regulatory Consulting - all at Evader.
A review of the current use of real-world data and evidence in HTA and payer appraisals, its potential role in lifecycle management, and how the early dialogue provided by Integrated Scientific Advice engagement can be used as a key tool in the planning and generation of RWE.
Published: November 1st 2019 | Updated:
